Allen Investment Management LLC Incyte Corp Transaction History

Allen Investment Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 04, 2020	SELL	$73.04 - $95.72 $1.38 Million - $1.81 Million	-18,863 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$63.56 - $88.17 $1.2 Million - $1.66 Million	18,863 New	18,863 $1.62 Million
Q4 2018 Feb 05, 2019	SELL	$58.5 - $69.94 $1.2 Million - $1.43 Million	-20,488 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$83.06 - $100.98 $1.33 Million - $1.62 Million	16,047 Added 361.34%	20,488 $1.71 Million
Q4 2017 Feb 13, 2018	SELL	$93.56 - $116.6 $272,259 - $339,306	-2,910 Reduced 39.59%	4,441 $421,000
Q3 2017 Nov 07, 2017	BUY	$109.15 - $138.27 $318,063 - $402,918	2,914 Added 65.68%	7,351 $858,000
Q3 2016 Sep 22, 2017	SELL	N/A	-2,486 Reduced 35.91%	4,437 $418,000
Q3 2015 Sep 22, 2017	BUY	N/A	1,740 Added 33.57%	6,923 $764,000
Q4 2014 Sep 22, 2017	BUY	N/A	5,183	5,183 $379,000

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.3B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Allen Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Allen Investment Management LLC with notifications on news.